Why the study?
To investigate the role of Hsp70 in angiotensin II-induced epithelial-mesenchymal transition and the protective effect of losartan in proximal tubule cells from spontaneously hypertensive rats.
Does Losartan prevent Angiotensin II-induced epithelial mesenchymal transition in proximal tubule cells from spontaneously hypertensive rats through Hsp70?
Does Losartan prevent Angiotensin II-induced epithelial mesenchymal transition in proximal tubule cells from spontaneously hypertensive rats through Hsp70?
Losartan prevents Angiotensin II-induced epithelial to mesenchymal transition in proximal tubule cells from spontaneously hypertensive rats via an Hsp70-dependent mechanism.
Hsp70 modulation may mitigate hypertensive renal fibrosis in animals; leaves open clinical translation and human trials.
Background/Aims: Renal injury related to hypertension is characterized by glomerular and tubulointerstitial damage. The overactivation of the renin-angiotensin system mainly by angiotensin II (AII) seems to be a main contributor to progressive renal fibrosis. Epithelial to mesenchymal transition (EMT) is a mechanism that promotes renal fibrosis. Owing to heat shock protein 70 (Hsp70) cytoprotective properties, the chaperone exhibits an important potential as a therapeutic target. We investigate the role of Hsp70 on Angiotensin II induced epithelial mesenchymal transition within the Losartan effect in proximal tubule cells (PTCs) from a genetic model of hypertension in rats (SHR). Methods: Primary cell culture of PTCs from SHR and Wistar Kyoto (WKY) rats were stimulated with AII, treated with Losartan (L), (L+AII) or untreated (C c ). The functional Hsp70 role in Losartan effect, after silencing its expression by cell transfection, was determined by Immunofluorescence; Western blotting; Gelatin Zymography assays; Scratch wound assays; flow cytometry; and Live Cell Time-lapse microscopy. Results: (L) and (L+AII) treatments induced highly organized actin filaments and increased cortical actin in SHR PTCs. However, SHR PTCs (C c ) and (AII) treated cells showed disorganized actin. After Hsp72 knockdown in SHR PTCs, (L) was unable to stabilize the actin cytoskeleton. We demonstrated that (L) and (L+AII) increased E-cadherin levels and decreased vinculin, -SMA, vimentin, pERK, p38 and Smad2-3 activation compared to (AII) and (C c ) SHR PTCs. Moreover, (L) inhibited MMP-2 and MMP-9 secretion, reduced migration and cellular
No takes yet. Share an insight, caveat, or question.
Costantino et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: